Full-Time

Compliance Lead

Updated on 8/21/2026

Aegis Ventures

Aegis Ventures

11-50 employees

Launches AI-driven health tech companies

Compensation Overview

$160k - $180k/yr

+ Equity

Remote in USA + 2 more

More locations: Irvine, CA, USA | Columbus, OH, USA

Remote

Category
Legal & Compliance (1)
Required Skills
SOC 2
Mergers & Acquisitions (M&A)
HIPAA

Get referred to Aegis Ventures

See people who can refer or advise you

Requirements
  • At least 5 years of hands-on compliance experience at a B2B software-as-a-service or healthcare technology company.
  • Demonstrated ownership of Health Insurance Portability and Accountability Act compliance programs and working knowledge of HITRUST i1 or r2.
  • Experience with System and Organization Controls 2 Type II, including coordinating evidence, managing auditors, and closing gaps.
  • Ability to work cross-functionally with Engineering on technical controls.
  • Strong written communication skills for policy writing, questionnaire responses, and executive summaries.
  • Ability to build structure in ambiguous environments.
Responsibilities
  • Own and operationalize Avandra's compliance program and roadmap across HIPAA, HITRUST, and SOC 2, including certification timelines and recertification cycles.
  • Maintain the risk register and conduct company-wide risk assessments on a defined cadence.
  • Author, publish, and maintain security and compliance policies and procedures.
  • Evaluate emerging frameworks, including ISO 27001 and the NIST Cybersecurity Framework, for relevance as the company scales.
  • Coordinate evidence collection, gap assessments, and control testing across Engineering, Operations, and People teams.
  • Manage relationships with external assessors and compliance-automation platforms.
  • Maintain audit-ready documentation continuously.
  • Own the vendor security intake and assessment process.
  • Respond to customer security questionnaires, requests for proposals, and due diligence requests, and represent the company's compliance posture to health system partners.
  • Conduct compliance assessments for acquisition targets, including evaluating protected health information handling practices, existing certifications, policy maturity, and open audit findings.
  • Own the post-acquisition compliance integration playbook, including gap analysis, remediation roadmap, and timeline for bringing acquired entities under the company's compliance framework.
  • Assess and rationalize subsidiary compliance programs and identify redundancies, coverage gaps, and certification consolidation opportunities.
  • Serve as the compliance integration contributor in cross-functional mergers and acquisitions workstreams with Legal, Finance, and Engineering.
  • Maintain a consolidated compliance posture across all entities and ensure subsidiaries operate within the company's policy and control framework.
  • Develop and deliver company-wide compliance training, including onboarding programs tailored to acquired teams.
  • Translate complex regulatory requirements into clear, actionable guidance for non-compliance teams.
Desired Qualifications
  • Experience supporting compliance assessments or integration work in mergers and acquisitions contexts.
  • Familiarity with multi-entity or subsidiary compliance program management.
  • Certified Information Systems Security Professional, Certified Information Security Manager, HealthCare Information Security and Privacy Practitioner, or equivalent certification.
  • Experience with compliance automation tools such as Vanta, Drata, or Tugboat Logic.
  • Familiarity with protected health information data flows, health data integrations, and healthcare data contracts.
  • Prior experience at a growth-stage startup where the compliance program was being created rather than inherited.

Aegis Ventures is a startup studio that partners with entrepreneurs and industry leaders to originate, launch, and scale new companies focused on AI and health tech. It operates a platform that combines market-shaping ideas, permanent growth capital, and ambitious people to identify opportunities, fund them long-term, and provide hands-on operational support. Unlike traditional funds, it creates companies in-house with a built-in path to rapid growth, with a strong emphasis on transforming healthcare quality, access, and cost. Its goal is to build companies capable of vast impact by using technology to improve health outcomes and societal wellbeing.

Company Size

11-50

Company Stage

N/A

Total Funding

$33.1M

Headquarters

New York City, New York

Founded

2020

Get referred to Aegis Ventures

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 Wavelet $7M seed expands Aegis into fetal medicine commercialization.
  • May 2026 whitepaper and Bunny Ellerin hire signal aggressive platform-building in medtech AI.
  • Portfolio now includes Ascertain, Avandra, Caregentic, Hume, Optain, and Wavelet, broadening optionality.

What critics are saying

  • Ascertain launched in 2022; five companies still concentrate value in unproven early-stage bets.
  • Wavelet needs regulatory clearance and hospital adoption before revenue, delaying scale.
  • If Northwell or Yale withdraws, Aegis loses its core sourcing and distribution moat.

What makes Aegis Ventures unique

  • Northwell partnership plus permanent growth capital gives proprietary clinical distribution.
  • Yale relationship and 2026 Wavelet seed show university-to-market commercialization engine.
  • Five launched AI health companies and $200M+ portfolio capital prove repeatable studio model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Flexible Work Hours

Company Equity

Wellness Program

Mental Health Support

Company News

Yahoo Finance
Apr 14th, 2026
Yale-born fetal brain monitoring startup Wavelet secures $7M to prevent birth injuries

Wavelet Medical has secured $7 million in seed funding from Aegis Ventures to commercialise the first non-invasive, AI-powered fetal electroencephalography monitoring platform. The technology, developed at Yale, aims to detect fetal brain distress in real time and prevent avoidable brain injury at birth. Founded by Liz Golden, Dr Emily Lee and Dr Jose Cortes-Briones, Wavelet uses EEG captured through the mother's abdomen and reconstructed with AI algorithms to identify neurological distress, addressing limitations of traditional fetal heart rate monitoring, which is indeterminate in up to 85% of births. The platform targets a significant problem: over 35,000 infants suffer birth-related brain injuries annually in the US alone. Wavelet's partnership with Aegis Ventures will accelerate product development, clinical adoption and commercialisation of the technology.

PR Newswire
Apr 14th, 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine

/PRNewswire/ -- A breakthrough in fetal brain monitoring developed at Yale is moving from laboratory discovery to global commercialization through a pivotal...

Teknovation.biz
Nov 25th, 2024
News & Notes | Foundersforge Joins Village Capital’S Resource Iii Program For Entrepreneur Support Organizations

From Knoxville: The Knoxville Technology Council is asking local business representatives to complete its latest KTech Pulse 2024 Survey. Noting that the organization wants to get the pulse of Knoxville-area... The post News Notes | FoundersForge joins Village Capitals Resource III Program for Entrepreneur Support Organizations appeared first on Teknovation.biz.

Aegis Ventures
Oct 10th, 2023
Our Focus

We are driven by the mission to build companies that solve society's greatest problems, informed by the belief that the nexus of profits and purpose will create a virtuous cycle of impact that moves the world forward.

PR Newswire
Aug 22nd, 2023
Ascertain Announces Leadership Team With Appointment Of Ceo Mark Michalski, M.D. And Executive Chairman Gregg Fergus

Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si